Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
4.23x
As of Jun 29, 2026
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Jun 29, 2026 | 4.23x |
| Jun 26, 2026 | 4.37x |
| Jun 25, 2026 | 4.33x |
| Jun 24, 2026 | 4.56x |
| Jun 23, 2026 | 4.27x |
| Jun 22, 2026 | 4.37x |
| Jun 18, 2026 | 4.43x |
| Jun 17, 2026 | 3.90x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison